DK1131414T3 - Stabile, svækkede rabiesvirusmutanter og levende vacciner deraf - Google Patents

Stabile, svækkede rabiesvirusmutanter og levende vacciner deraf

Info

Publication number
DK1131414T3
DK1131414T3 DK99973064T DK99973064T DK1131414T3 DK 1131414 T3 DK1131414 T3 DK 1131414T3 DK 99973064 T DK99973064 T DK 99973064T DK 99973064 T DK99973064 T DK 99973064T DK 1131414 T3 DK1131414 T3 DK 1131414T3
Authority
DK
Denmark
Prior art keywords
stable
rabies virus
live vaccines
virus mutants
attenuated rabies
Prior art date
Application number
DK99973064T
Other languages
English (en)
Inventor
Teshome Mebatsion
Karl Klaus Conzelmann
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Application granted granted Critical
Publication of DK1131414T3 publication Critical patent/DK1131414T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20161—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK99973064T 1998-11-27 1999-11-19 Stabile, svækkede rabiesvirusmutanter og levende vacciner deraf DK1131414T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98204001 1998-11-27
PCT/EP1999/009101 WO2000032755A1 (en) 1998-11-27 1999-11-19 Stable, attenuated rabies virus mutants and live vaccines thereof

Publications (1)

Publication Number Publication Date
DK1131414T3 true DK1131414T3 (da) 2007-06-18

Family

ID=8234392

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99973064T DK1131414T3 (da) 1998-11-27 1999-11-19 Stabile, svækkede rabiesvirusmutanter og levende vacciner deraf

Country Status (16)

Country Link
US (1) US6719981B1 (da)
EP (1) EP1131414B1 (da)
AR (1) AR021406A1 (da)
AT (1) ATE356202T1 (da)
AU (1) AU1386100A (da)
BR (1) BR9915703B1 (da)
CA (1) CA2352231C (da)
CY (1) CY1106570T1 (da)
DE (1) DE69935445T2 (da)
DK (1) DK1131414T3 (da)
ES (1) ES2283150T3 (da)
ID (1) ID28968A (da)
IL (2) IL143149A0 (da)
PT (1) PT1131414E (da)
TR (1) TR200101445T2 (da)
WO (1) WO2000032755A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE316572T1 (de) 2001-04-23 2006-02-15 Akzo Nobel Nv Attenuierte rekombinante stabile tollwutvirusmutanten und lebendimpfstoffe
EP1434862A4 (en) 2001-07-20 2005-04-06 Univ Georgia Res Found ATTENUATED TOLL WUTVIRUS WITH NUCLEOPROTEIN MUTATION AT THE PHOSPHORYLATION CENTER FOR VACCINATION AGAINST FOLLOW-UP AND GENE THERAPY IN THE CNS
CA2943039C (en) 2005-10-14 2018-11-06 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Rabies virus compositions and methods
US7785874B2 (en) * 2007-01-11 2010-08-31 The Salk Institute For Biological Studies Compositions and methods for monosynaptic transport
TW200907058A (en) * 2007-05-30 2009-02-16 Wyeth Corp Raccoon poxvirus expressing rabies glycoproteins
WO2012106490A1 (en) 2011-02-03 2012-08-09 The Government Of The U.S.A., As Represented By The Secretary, Department Of Health & Human Services Multivalent vaccines for rabies virus and filoviruses
CN103865889B (zh) * 2014-04-03 2015-02-25 深圳市卫光生物制品股份有限公司 狂犬病病毒ctn鸡胚细胞适应株
EP3439695B1 (en) 2016-04-04 2022-05-04 The U.S.A. as represented by the Secretary, Department of Health and Human Services Multivalent vaccines for rabies virus and coronaviruses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2580176B1 (fr) * 1985-04-12 1988-02-26 Centre Nat Rech Scient Vaccin antirabique avirulent
FR2633832B1 (fr) * 1988-07-05 1991-05-31 Virbac Vaccin antirabique avirulent
FR2693655B1 (fr) * 1992-07-20 1994-10-14 Virbac Vaccin antirabique avirulent.
SE0002498D0 (sv) 2000-07-03 2000-07-03 Stefan Schwartz Papillomavirus vaccine
WO2003050398A1 (en) 2001-12-10 2003-06-19 Donaldson Company, Inc. Exhaust treatment control system for an internal combustion engine
DE102004009653A1 (de) 2004-02-27 2005-09-22 Cycos Ag Kommunikationsserver und Verfahren zum Aufbau und Betrieb einer Konferenz-Kommunikationsverbindung

Also Published As

Publication number Publication date
US6719981B1 (en) 2004-04-13
IL143149A (en) 2007-12-03
IL143149A0 (en) 2002-04-21
CY1106570T1 (el) 2012-01-25
PT1131414E (pt) 2007-04-30
ID28968A (id) 2001-07-19
AR021406A1 (es) 2002-07-17
BR9915703A (pt) 2001-08-14
ATE356202T1 (de) 2007-03-15
EP1131414B1 (en) 2007-03-07
AU1386100A (en) 2000-06-19
EP1131414A1 (en) 2001-09-12
BR9915703B1 (pt) 2012-09-04
CA2352231A1 (en) 2000-06-08
DE69935445D1 (de) 2007-04-19
CA2352231C (en) 2010-06-01
TR200101445T2 (tr) 2001-10-22
WO2000032755A1 (en) 2000-06-08
DE69935445T2 (de) 2007-11-29
ES2283150T3 (es) 2007-10-16

Similar Documents

Publication Publication Date Title
DK1126876T3 (da) Adjuvanssystemer og vacciner
DK1131301T3 (da) 2-phenylbenzimidazoler og 2-phenylindoler, fremstilling af anvendelse heraf
NO20031035L (no) Öynettverk og fremgangsmåte for drift av et öynettverk
GB2337755B (en) Virus vaccine
ATE287728T1 (de) Adjuvierte rekombinante lebendimpfstoffe gegen influenza- oder herpesviren
NO20004104D0 (no) Preparater omfattende virus og fremgangsmÕter for konsentrering av viruspreparater
EP1083926A4 (en) VACCINE
DK1175486T3 (da) Fremgangsmåde til konservering af virus og mycoplasma
NO20030239D0 (no) Modifisert virus
DK0841392T3 (da) Svækket levende Neospora vaccine
DK2116257T3 (da) Parenterale vaccineformuleringer og anvendelser deraf
FI20002134L (fi) Koodisynkronointimenetelmä ja vastaanotin
EP1345623A4 (en) IMMUNOGENE PROTEOLIPOSOME AND ITS USE
IS5777A (is) Bóluefnisvakið lifrarbólgu B veiruafbrigði og notkun þess
ATE356202T1 (de) Attenuierte stabile tollwutvirusmutante und lebende impfstoffe
MXPA03002875A (es) Composicion de vacuna y metodo de estabilizacion.
NO20005599D0 (no) Vaksine
ATE316572T1 (de) Attenuierte rekombinante stabile tollwutvirusmutanten und lebendimpfstoffe
EP1105154A4 (en) BACTERIAL VACCINES WITH SUPERANTIGENES
DE69835346D1 (de) Vakzine gegen infektiöse bursitis
IS5778A (is) Stökkbrigði af mennskri lifrarbólgu B veiru og notkun hennar
DE60144426D1 (de) Verteiltes nachrichtensystem und -verfahren
DK1105498T3 (da) HIV vaccine
IL149173A0 (en) Attenuated recombinant rabies virus mutants and live vaccines thereof
SE0000932D0 (sv) System och förfarande